478 related articles for article (PubMed ID: 32442178)
1. Computed tomography-derived radiomic signature of head and neck squamous cell carcinoma (peri)tumoral tissue for the prediction of locoregional recurrence and distant metastasis after concurrent chemo-radiotherapy.
Keek S; Sanduleanu S; Wesseling F; de Roest R; van den Brekel M; van der Heijden M; Vens C; Giuseppina C; Licitra L; Scheckenbach K; Vergeer M; Leemans CR; Brakenhoff RH; Nauta I; Cavalieri S; Woodruff HC; Poli T; Leijenaar R; Hoebers F; Lambin P
PLoS One; 2020; 15(5):e0232639. PubMed ID: 32442178
[TBL] [Abstract][Full Text] [Related]
2. Computed Tomography Radiomics Predicts HPV Status and Local Tumor Control After Definitive Radiochemotherapy in Head and Neck Squamous Cell Carcinoma.
Bogowicz M; Riesterer O; Ikenberg K; Stieb S; Moch H; Studer G; Guckenberger M; Tanadini-Lang S
Int J Radiat Oncol Biol Phys; 2017 Nov; 99(4):921-928. PubMed ID: 28807534
[TBL] [Abstract][Full Text] [Related]
3. Outcome prediction of head and neck squamous cell carcinoma by MRI radiomic signatures.
Mes SW; van Velden FHP; Peltenburg B; Peeters CFW; Te Beest DE; van de Wiel MA; Mekke J; Mulder DC; Martens RM; Castelijns JA; Pameijer FA; de Bree R; Boellaard R; Leemans CR; Brakenhoff RH; de Graaf P
Eur Radiol; 2020 Nov; 30(11):6311-6321. PubMed ID: 32500196
[TBL] [Abstract][Full Text] [Related]
4. Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study.
Kakino R; Nakamura M; Mitsuyoshi T; Shintani T; Kokubo M; Negoro Y; Fushiki M; Ogura M; Itasaka S; Yamauchi C; Otsu S; Sakamoto T; Sakamoto M; Araki N; Hirashima H; Adachi T; Matsuo Y; Mizowaki T
Med Phys; 2020 Sep; 47(9):4634-4643. PubMed ID: 32645224
[TBL] [Abstract][Full Text] [Related]
5. Clinical utility of
Ha SC; Roh JL; Kim JS; Lee JH; Choi SH; Nam SY; Kim SY
Acta Otolaryngol; 2019 Sep; 139(9):810-815. PubMed ID: 31274365
[No Abstract] [Full Text] [Related]
6.
van den Bosch S; Doornaert PAH; Dijkema T; Zwijnenburg EM; Verhoef LCG; Hoeben BAW; Kasperts N; Smid EJ; Terhaard CHJ; Kaanders JHAM
Radiother Oncol; 2020 Jan; 142():107-114. PubMed ID: 31439447
[TBL] [Abstract][Full Text] [Related]
7. Predictive and prognostic value of CT based radiomics signature in locally advanced head and neck cancers patients treated with concurrent chemoradiotherapy or bioradiotherapy and its added value to Human Papillomavirus status.
Ou D; Blanchard P; Rosellini S; Levy A; Nguyen F; Leijenaar RTH; Garberis I; Gorphe P; Bidault F; Ferté C; Robert C; Casiraghi O; Scoazec JY; Lambin P; Temam S; Deutsch E; Tao Y
Oral Oncol; 2017 Aug; 71():150-155. PubMed ID: 28688683
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
[TBL] [Abstract][Full Text] [Related]
9. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and molecular imaging biomarker signature for the prediction of failure site after chemoradiation for head and neck squamous cell carcinoma.
Rasmussen GB; Håkansson KE; Vogelius IR; Rasmussen JH; Friborg JT; Fischer BM; Schumaker L; Cullen K; Therkildsen MH; Bentzen SM; Specht L
Acta Oncol; 2017 Nov; 56(11):1562-1570. PubMed ID: 28840766
[TBL] [Abstract][Full Text] [Related]
11. Functional imaging early during (chemo)radiotherapy for response prediction in head and neck squamous cell carcinoma; a systematic review.
Martens RM; Noij DP; Ali M; Koopman T; Marcus JT; Vergeer MR; de Vet H; de Jong MC; Leemans CR; Hoekstra OS; de Bree R; de Graaf P; Boellaard R; Castelijns JA
Oral Oncol; 2019 Jan; 88():75-83. PubMed ID: 30616800
[TBL] [Abstract][Full Text] [Related]
12. Utility of adding Radiomics to clinical features in predicting the outcomes of radiotherapy for head and neck cancer using machine learning.
Gangil T; Sharan K; Rao BD; Palanisamy K; Chakrabarti B; Kadavigere R
PLoS One; 2022; 17(12):e0277168. PubMed ID: 36520945
[TBL] [Abstract][Full Text] [Related]
13. Development of a Model Based on Delta-Radiomic Features for the Optimization of Head and Neck Squamous Cell Carcinoma Patient Treatment.
Šedienė S; Kulakienė I; Urbonavičius BG; Korobeinikova E; Rudžianskas V; Povilonis PA; Jaselskė E; Adlienė D; Juozaitytė E
Medicina (Kaunas); 2023 Jun; 59(6):. PubMed ID: 37374377
[No Abstract] [Full Text] [Related]
14. Application of contrast-enhanced CT radiomics in prediction of early recurrence of locally advanced oesophageal squamous cell carcinoma after trimodal therapy.
Tang S; Ou J; Liu J; Wu YP; Wu CQ; Chen TW; Zhang XM; Li R; Tang MJ; Yang LQ; Tan BG; Lu FL; Hu J
Cancer Imaging; 2021 May; 21(1):38. PubMed ID: 34039403
[TBL] [Abstract][Full Text] [Related]
15. Use of Diffusion-Weighted Imaging and
Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
[TBL] [Abstract][Full Text] [Related]
16. 2D and 3D convolutional neural networks for outcome modelling of locally advanced head and neck squamous cell carcinoma.
Starke S; Leger S; Zwanenburg A; Leger K; Lohaus F; Linge A; Schreiber A; Kalinauskaite G; Tinhofer I; Guberina N; Guberina M; Balermpas P; von der Grün J; Ganswindt U; Belka C; Peeken JC; Combs SE; Boeke S; Zips D; Richter C; Troost EGC; Krause M; Baumann M; Löck S
Sci Rep; 2020 Sep; 10(1):15625. PubMed ID: 32973220
[TBL] [Abstract][Full Text] [Related]
17. Prognostic role of pre-treatment magnetic resonance imaging (MRI)-based radiomic analysis in effectively cured head and neck squamous cell carcinoma (HNSCC) patients.
Alfieri S; Romanò R; Bologna M; Calareso G; Corino V; Mirabile A; Ferri A; Bellanti L; Poli T; Marcantoni A; Grosso E; Tarsitano A; Battaglia S; Blengio F; De Martino I; Valerini S; Vecchio S; Richetti A; Deantonio L; Martucci F; Grammatica A; Ravanelli M; Ibrahim T; Caruso D; Locati LD; Orlandi E; Bossi P; Mainardi L; Licitra LF
Acta Oncol; 2021 Sep; 60(9):1192-1200. PubMed ID: 34038324
[TBL] [Abstract][Full Text] [Related]
18. Prediction of local recurrence and distant metastasis using radiomics analysis of pretreatment nasopharyngeal [18F]FDG PET/CT images.
Peng L; Hong X; Yuan Q; Lu L; Wang Q; Chen W
Ann Nucl Med; 2021 Apr; 35(4):458-468. PubMed ID: 33543393
[TBL] [Abstract][Full Text] [Related]
19. CT imaging during treatment improves radiomic models for patients with locally advanced head and neck cancer.
Leger S; Zwanenburg A; Pilz K; Zschaeck S; Zöphel K; Kotzerke J; Schreiber A; Zips D; Krause M; Baumann M; Troost EGC; Richter C; Löck S
Radiother Oncol; 2019 Jan; 130():10-17. PubMed ID: 30087056
[TBL] [Abstract][Full Text] [Related]
20. Comparison of PET and CT radiomics for prediction of local tumor control in head and neck squamous cell carcinoma.
Bogowicz M; Riesterer O; Stark LS; Studer G; Unkelbach J; Guckenberger M; Tanadini-Lang S
Acta Oncol; 2017 Nov; 56(11):1531-1536. PubMed ID: 28820287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
